News | June 22, 2022
Briefs: Marksans Pharma and Alkem
The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.
The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.
With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg
Ibuprofen and Famotidine tablets approved by FDA
The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access
It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.
Subscribe To Our Newsletter & Stay Updated
